(4-Fluoro-3-(methoxy(methyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

4-Chloro-6-hydroxyquinoline, 95.0%, 250mg

Piperidine-2,6-dione, 98.0%, 500g

2-(2,3-Dichlorophenyl)cyclopropan-1-amine hydrochloride, 95%, 100mg

Chloroquine>98.0%(HPLC)(T)1g

2,6-Pyridinedimethanol>98.0%(GC)(T)5g

tert-Butyldimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)silane, 97%, 10g

2,3-Diamino-6-chlorobenzonitrile, 97%, 1g

4,4'-bi-1,3-thiazole-2,2'-diamine, 95.0%, 500mg

tert-butyl (2S)-2-[4-(4-iodophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 97%, 250mg

2,6-Dibromo-4,4-di-n-octyldithieno[3,2-b:2',3'-d]silole>98.0%(GC)100mg

1-(3-Bromo-5-fluoropyridin-2-yl)ethanone, 97%, 250mg

4-Hydrazinebenzoic acid, min. 97%, for synthesis, 100 g, glass packaging